Oncology & Cancer

Possible new druggable target in Ewing's Sarcoma

Ewing's Sarcoma is an aggressive pediatric cancer, most commonly caused by the improper fusion of the gene EWS with the gene FLI1. Though the cause has long been known, therapeutic targeting of this fusion has to date proven ...

Medical research

Researchers develop new database of druggable fusion targets

When sections from two separate genes merge due to various factors, such as translocation or splicing, the hybrid that is formed is called a gene fusion. In recent years, it has been discovered that these fusion events play ...

Oncology & Cancer

Frequent sun exposure may cue gene fusion found in skin cancer

A fusion gene is a single composite gene resulting from the combination of two formerly independent genes. Researchers from Kumamoto University, Japan have determined that a particular fusion gene is often found in cutaneous ...

Oncology & Cancer

Mouse model improves understanding of clear cell sarcoma

Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue ...

page 8 from 11